Literature DB >> 851126

Pharmacokinetics of propranolol, quinidine, procainamide and lidocaine in chronic renal disease.

D T Lowenthal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 851126     DOI： 10.1016/0002-9343(77)90411-9

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  6 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  Alteration of drug-protein binding in renal disease.

Authors:  M M Reidenberg; D E Drayer
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

3.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

4.  Disposition and pharmacodynamics of diuretics and antihypertensive agents in renal disease.

Authors:  B L Mirkin; T P Green; R F O'Dea
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

5.  Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.

Authors:  J Fabre; H M Fox; P Dayer; L Balant
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 6.  Drug therapy in haemodialysis patients. Special considerations in the elderly.

Authors:  W L St Peter; J L Clark; O M Levos
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 4.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.